Literature DB >> 7919308

The promise and reality of fixed-dose combinations with rifampicin. A joint statement of the International Union Against Tuberculosis and Lung Disease and the Tuberculosis Programme of the World Health Organization.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7919308     DOI： 10.1016/0962-8479(94)90004-3

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN： 0962-8479


× No keyword cloud information.
  8 in total

Review 1.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Fixed-dose combination drugs for tuberculosis: application in standardised treatment regimens.

Authors:  Bjørn Blomberg; Bernard Fourie
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Health technology assessment of fixed-dose combination regimen in treatment of newly diagnosed smear-positive pulmonary tuberculosis: A meta-analysis.

Authors:  Gurpreet Singh; Seema Patrikar; D R Basannar; V K Bhatti
Journal:  Med J Armed Forces India       Date:  2019-03-25

4.  Assessing the risk of birth defects associated with exposure to fixed-dose combined antituberculous agents during pregnancy in rats.

Authors:  O Awodele; E B Patrick; Esther Oluwatoyin Agbaje; A A Oremosu; S C Gbotolorun
Journal:  ScientificWorldJournal       Date:  2012-05-03

Review 5.  Treatment of Drug Susceptible Pulmonary Tuberculosis.

Authors:  Hong-Joon Shin; Yong-Soo Kwon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30

Review 6.  Respiratory review of 2014: tuberculosis and nontuberculous mycobacterial pulmonary disease.

Authors:  Cheol Kyu Park; Yong Soo Kwon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-10-31

7.  Relative bioavailability of rifampicin in four Chinese fixed-dose combinations compared with rifampicin in free combinations.

Authors:  Hui Zhu; Shao-Chen Guo; Lan-Hu Hao; Cheng-Cheng Liu; Bin Wang; Lei Fu; Ming-Ting Chen; Lin Zhou; Jun-Ying Chi; Wen Yang; Wen-Juan Nie; Yu Lu
Journal:  Chin Med J (Engl)       Date:  2015-02-20       Impact factor: 2.628

8.  Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.

Authors:  Abraham Aseffa; Joseph N Chukwu; Mahnaz Vahedi; Emmanuel N Aguwa; Ahmed Bedru; Tesfamariam Mebrahtu; Oliver C Ezechi; Getnet Yimer; Lawrence K Yamuah; Girmay Medhin; Cathy Connolly; Wasima Rida; Getachew Aderaye; Alimuddin I Zumla; Philip C Onyebujoh
Journal:  PLoS One       Date:  2016-06-20       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.